February 1, 2011 at 1:00 PM EST (60 minutes)
WEBINAR:
Personalized Medicine: Genetic Testing 101: How, What are the Benefits? Cost Effectiveness
The International Society for Cardiovascular Translational Research and the American College of Cardiology bring you the Innovation Institute's webinar series "DNA and RNA Biomarkers: Personalized Medicine in Everyday Practice" free of charge. This series of six one-hour webinars will help the cardiology clinician understand the role of genetic testing and it practical use in her/his daily practice. Join us for the first program in this series to learn about the basics of genetic testing.

March 17, 2011 at 1:00 PM EST (60 minutes)
WEBINAR: 
Personalized Medicine: Warfarin Genetic Testing — Are DNA Biomarkers
Useful for Warfarin Dosing?

April 2, 2011
ISCTR 4th Annual Meeting
The goal of this meeting is to bring together leaders in separate disciplines to discuss and highlight strategies for open collaboration to expedite scientific discoveries into clinical application and make clear progress in the steps towards evidence based medicine.

April 3-4, 2011
Cardiovascular Innovations Forum
Bridging the Future of Science to the Present
The American College of Cardiology, Elsevier Business Solutions and the International Society for Cardiovascular Translational Research join together to create the CVInnovations Forum, a single location at ACC.11, where you can see the latest in cardiovascular research and cardiovascular product development. Stop by during exhibit hours, on Sunday, April 3 and Monday, April 4, to hear presentations and see the latest technology in the cardiovascular world.

May 16, 2011 at 1:00 PM EST (60 minutes)
WEBINAR:
Personalized Medicine: Plavix/Clopidogrel Genetic Testing

June 20-21, 2011
ABCAM: Cardiomyocyte Regeneration and Protection Meeting


Program 4 (Oct 3, 2 pm EST): Personalized Medicine: Genetic Testing for Sudden Cardiac Death: How are DNA biomarkers best used to identify individuals at risk for Sudden Cardiac Death?

The fourth webinar in this series will address how DNA biomarkers and genetic screening can be used in the setting of sudden cardiac death. This short 30 minute webinar will provide critical updates for Cardiologists from leading experts in the field of genetic screening and sudden cardiac death. These leading experts include Dr. Silvia Priori, Dr. Peter Schwartz, and Dr. Jeffery Towbin. Current state of the art genetic screening options will be discussed as well as how these screening options can be applied to your clinical practice.

Early identification of patients and family members at risk of developing sudden cardiac death through genetic screening is an important step forward in cardiovascular medicine.

Program 5 (November 2, 12 EST): Personalized Medicine: Genetic Testing for Hypertrophic Cardiomyopathy: DNA Biomarkers for Hypertrophic Cardiomyopathy.

The fifth webinar in this series will address how DNA biomarkers and genetic screening can be used in the setting of hypertrophic cardiomyopathy. This short 30 minute state-of-the-art webinar will provide critical updates for Cardiologists from leading experts in the field of genetic screening and hypertrophic cardiomyopathy. Current state of the art genetic screening tests will be outlined as well as how these tests can be best used in your clinical practice to manage patient care. Practical guidelines for how and when to use these tests will be discussed. The leading experts include Dr. Jeffrey Towbin and Dr. Ray Hershberger. Early identification of patients and family members at risk of developing hypertrophic cardiomyopathy may prevent or delay the complications that accompany this serious form of heart disease and improve patient lives.

November 4 - 5, 2011 | Spain
Evolving Challenges in Promoting Cardiovascular Health
Spearheaded by Dr. Valentin Fuster, this international, 2-day, scientific symposium will be focused on the promotion of cardiovascular health through molecular biology, clinical pathophysiology and population research with the intent of reducing the public health burden that cardiovascular disease poses in developed countries, and increasingly in low- and middle-income countries as well. www.nyas.org/Cardiovascular

Program 6 (Dec 19, 2011, 2 pm EST): Personalized Medicine: Genetic testing for Familial Dilated Cardiomyopathy: DNA biomarkers for Familial Dilated Cardiomyopathy

The sixth webinar in this series will address how DNA biomarkers and genetic screening can be used in the setting of dilated cardiomyopathy. This short state-of-the-art webinar will provide critical updates for Cardiologists from leading experts in the field of genetic screening and dilated cardiomyopathy.

Current state of the art genetic screening tests will be outlined as well as how these tests can be best used in your clinical practice to manage patient care. Practical guidelines for how and when to use these tests will be discussed. The leading experts include Dr. Jeffrey Towbin and Dr. Ray Hershberger.

Early identification of patients and family members at risk of developing dilated cardiomyopathy may prevent or delay the complications that accompany this serious form of heart disease and improve patient lives.

Feb 3, 2012
Peripheral Academic Research Consortium: Silver Spring, MD
The Academic Research Consortium has been active over the past decade in developing consensus definitions and promoting improved clinical trial design in areas such as stent thrombosis, bleeding, and valve replacement.
Location: 10903 New Hampshire Ave, Silver Spring, MD 20993-0002